Long-Term Prognosis in Children with Kawasaki Disease: Dr. David Liew
Dr. David Liew reviews abstract #0937 presented at the 2020 ACR annual meeting.
COVID 19 and Rheumatic Disease: Dr. Jeffrey Sparks
Dr. Jeffrey Sparks reviews COVID-19 related abstracts #0430 and L01 at the 2020 ACR annual meeting.
Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein
Dr. Eric Dein reviews abstract #0483 presented Friday at the ACR annual meeting.
Rheumatoid Arthritis and ILD: Dr. Janet Pope interviews Dr. Jeffrey Sparks
Dr. Janet Pope talks with Dr. Jeffrey Sparks about abstracts #0392, #0491, #1198 and #0489 presented at the ACR annual meeting.
SKIPPAIN Trial: Dr. Sheila Reyes
Dr. Sheila Reyes reviews abstract #0899 presented at the 2020 ACR annual meeting.
Improving Response to Pegloticase: Dr. Nicola Dalbeth
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.
Nomenclature, Uveitis and Other Spondyloarthritis Features: Dr. Lianne Gensler
Dr. Gensler reviews her top selections for ACR 2020 today, including abstract #0881 and #0876. She also highlighted the study group on spondyloarthritis, which focused on nomenclature.
Infection in rheumatic diseases: Dr. Mrinalini Dey interviews Dr. James Galloway
Dr. Mrinalini Dey interviews Dr. James Galloway on infection in rheumatic diseases, and the studies and presentations he's interested in on infection at the 2020 ACR annual meeting.
Male Osteoporosis: Dr. Kathryn Dao
Dr. Kathryn Dao reviews abstract #0533 presented at the 2020 ACR annual meeting.
Warfarin and Risk of Hip and Knee Replacements: Dr. Mrinalini Dey
Dr. Mrinalini Dey reviews abstract #0934 presented Saturday at the 2020 ACR annual meeting.
COVID and Rheumatic Disease Patients: Dr. Kevin Winthrop
Portland-based Dr. Kevin Winthrop from OHSU discusses Saturday ACR 2020 posters #0623 and #0629 related to COVID-19 and RA patients.
Subclinical Synovitis: Dr Eric Dein
Dr. Eric Dein reviews abstract #0481 presented at the 2020 ACR annual meeting, and reviews the Twitter poll he posted on whether clinicians would start DMARDs in this scenario.
GCAN Report: Gout, Urate and the repositioning of innate immunity: Dr. Michael Pillinger
NYU's Dr. Michael Pillinger promises deeper looks at ACR 2020 activity regarding gout, but starts out reporting data from GCAN.
Significance of ANA+ in Managing RA: Dr Eric Dein
Dr. Eric Dein reviews abstract #0755 presented at the ACR annual meeting.
Shifting Treatment Paradigms in Psoriatic Arthritis: Dr. Eric Ruderman
Chicago-based Dr. Eric Ruderman discussed the shifting treatment paradigms in psoriatic arthritis by reviewing abstracts #0504 and #2026 at ACR 2020.
Poster Hall